These ASX 200 companies are placing new bosses at the helm

Is new blood at the top exactly what the doctor ordered for these underperforming companies?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The people in the driver's seat of a company can make or break it. Therefore, it's worth paying attention when an ASX 200 company — or any listed company for that matter — sees a change in its management.

It can be especially crucial after an extended run of poor performance. Like a plant, companies sometimes need to prune old branches to create healthy new shoots. The process can breathe new life into a withering business if done right.

Today, two multi-billion-dollar companies have announced new blood in their highest ranks. The ASX 200 members flexing fresh CEOs are Perpetual Ltd (ASX: PPT) and Atlas Arteria Group (ASX: ALX).

Both companies have dramatically failed to outperform the S&P/ASX 200 Index (ASX: XJO) over the past five years. The chart above graphically shows this by comparing the companies' share prices against the benchmark.

A man standing in front of co-workers extends his hand in welcome

Image source: Getty Images

Who's taking the reins of these ASX 200 companies?

After struggling with dwindling profits for several years, Perpetual is instating a new leader. The Australian wealth manager has appointed Bernard Reilly as chief executive officer and managing director, effective 2 September.

Perpetual's move to appoint Reilly arrives as the company undergoes a transformation. As covered earlier this year, the 138-year-old financials business is offloading its wealth management and corporate trust business to zero in on operating a global multi-boutique asset management business.

The newly appointed CEO of Perpetual previously led the Australian Retirement Trust — one of the largest super funds, managing the superannuation of more than 2.3 million Australians. Perpetual chair Tony D'Aloisio said, "[…] Bernard has extensive first-hand experience in managing client monies and a strong understanding of the challenges facing the asset management sector."

Reilly's fixed remuneration under the appointment is $1,000,000 (including superannuation), in addition to various short-term and long-term incentives.

What about the other ASX 200 company, Atlas Arteria?

The private toll road operator has poached its competitor's chief commercial officer for the top job. That's right, Hugh Wehby of Transurban Group (ASX: TCL) will be packing up and moving across to the rival within the next 27 weeks.

According to Atlas Arteria's chair, Debbie Goodin:

Hugh is coming in with a clear mandate to drive forward our strategy: to pursue operational excellence to drive value; to pursue growth opportunities related or adjacent to our current businesses; and to manage our balance sheet and capital so that we can unlock additional value for securityholders.

Wehby will receive a fixed remuneration of $1,450,000 (super inclusive). Additional cash payments and equity awards will also be provided to the incoming executive to compensate him for forfeited Transurban incentives.

Both ASX 200 companies' shares are mostly flat today despite the news.

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Transurban Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Westpac and CBA shares

A leading expert forecasts growing headwinds for Westpac and CBA shares.

Read more »

Man looking at digital holograms of graphs, charts, and data.
Broker Notes

Expert names 2 ASX tech shares to buy today

A top analyst says these two ASX tech stocks are well-positioned to outperform.

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the week for investors this Friday.

Read more »

Woman thinking in a supermarket.
Dividend Investing

Coles stock vs Woolworths shares: Who had the better dividend this week?

Let's check the receipts on Coles and Woolies this week.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

4 ASX All Ords shares with 40% to 90% upside post-results: experts

These shares have major upside potential, according to the experts.

Read more »

Woman looking at a laptop and thinking.
Broker Notes

4 ASX shares scoring upgrades in the final week of earnings season

Brokers have increased their ratings on Sigma Healthcare, Adairs, Netwealth, and other shares.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Buy, hold, sell: Netwealth, Sigma Healthcare, and Wesfarmers shares

The team at Morgans has given its verdict on these shares.

Read more »

Smiling kid flexing his muscles.
Broker Notes

3 ASX 200 shares to buy post-results: broker

Morgans has reviewed these companies' FY26 reports and given them a buy rating.

Read more »